A 56 year old female patient treated with carbimazole for hyperthyroidism developed agranulocytosis complicated by pneumonia. She was treated by sc administration of 6 micrograms/kg rhGM-CSF for 10 days. The first neutrophils appeared in the peripheral blood on the 4th day and normal numbers are reached on the 7th day of treatment. This was accompanied by a rapid resolution of fever. The use of growth factors may be justified in cases of drug-induced agranulocytosis.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Possible protective role of L-thyroxin on the parotid gland of adult male albino rat in carbimazole induced hypothyroidism: histological, histomorphometry, and ultrastructural study.
Ultrastruct Pathol
January 2022
Anatomy and Embryology, Faculty of Medicine, Fayoum University, Al Fayyum, Egypt.
Background: Thyroid disorders are among the most common metabolic disorders worldwide. Thyroid dysfunction affects salivary glands function, causing hyposalivation. It also provokes physiological and histological changes in parotid, submandibular, and in particular the sublingual gland.
View Article and Find Full Text PDFCarbimazole-induced cholestatic hepatitis in Graves' disease.
Indian J Endocrinol Metab
March 2013
Department of Endocrinology, Medwin Hospital, Hyderabad, Andhra Pradesh, India.
Antithyroid medications are one of the treatment options for Graves' disease. Carbimazole is widely used as the drug of choice, except in pregnancy, where propythiouracil is preferred by many. It is generally well-tolerated.
View Article and Find Full Text PDFTreatment of carbimazole-induced agranulocytosis and sepsis with granulocyte colony stimulating factor.
Int J Clin Pract
March 2003
Department of Diabetes and Endocrinology, Arrowe Park Hospital, Wirral, Cheshire, UK.
We present the management of agranulocytosis and neutropenic sepsis secondary to carbimazole with recombinant human granulocyte colony stimulating factor (G-CSF). A 72-year-old woman with a history of thyrotoxicosis presented with sore throat and fever two weeks after starting carbimazole. Investigations confirmed a leucopenia and neutropenia.
View Article and Find Full Text PDFMethimazole-induced hepatotoxicity.
Endocr Pract
December 2002
Department of Medicine, University of California, San Franscisco, California 94143-1640, USA.
Objective: To present the case of a patient with Graves' hyperthyroidism in whom treatment with methimazole led to severe cholestasis.
Methods: A detailed case report and an overview of previously published cases of methimazole- and carbimazole-induced hepatotoxicity, found in a MEDLINE search with use of methimazole, carbimazole, thionamides and antithyroid agents as subject headings, are provided.
Results: In a 36-year-old woman with severe hyperthyroidism, treatment with methimazole (20 mg twice daily) was initiated.
Carbimazole-induced agranulocytosis--a report of 2 recent cases.
Singapore Med J
September 1997
Department of Medicine, Alexandra Hospital, Singapore.
Carbimazole is a useful antithyroid drug with a rare potentially fatal complication of agranulocytosis. We report 2 cases presenting with this problem. One was treated supportively with barrier nursing and broad spectrum antibiotics, and the other needed use of a haemopoietic growth factor, granulocyte colony stimulating factor (G-CSF).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!